SCHEMBL9867302

SCHEMBL9867302

COc1cc(NC(C)=O)c([N+](=O)[O-])cc1C(=O)NC1CCN(Cc2ccc(Cl)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 13/20 0.57
DRD3 P35462 3/20 0.57
DRD2 P14416 2/20 0.57
CYP3A4 P08684 2/20 0.54
CYP1A2 P05177 1/20 0.54
ADRA2A P08913 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
ACHE P22303 1/20 0.54
SLC6A2 P23975 1/20 0.54
HTR2A P28223 1/20 0.54
HTR2C P28335 1/20 0.54
ADRA1A P35348 1/20 0.54
OPRK1 P41145 1/20 0.54
HTR2B P41595 1/20 0.54
CHRNA4 P43681 1/20 0.54
HTR3A P46098 1/20 0.54
SLC6A3 Q01959 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9867056 0.93 DRD4 (0.55) DRD4DRD3DRD2CYP3A4CYP1A2
SCHEMBL9867273 0.92 DRD4 (0.65) DRD4DRD3DRD2CYP3A4CYP1A2
SCHEMBL9867420 0.91 DRD4 (0.51) DRD4DRD3DRD2CYP3A4CYP1A2
SCHEMBL9868673 0.89 DRD4 (0.51) DRD4DRD3DRD2CYP3A4CYP1A2
Fumaric Acid SCHEMBL9866529 0.89 CYP3A4 (0.64) DRD4DRD3DRD2CYP3A4CYP1A2
Fumaric Acid SCHEMBL9866524 0.89 CYP3A4 (0.64) DRD4DRD3DRD2CYP3A4CYP1A2
SCHEMBL9866850 0.87 DRD4 (0.66) DRD4DRD3DRD2CYP3A4CYP1A2
SCHEMBL9866864 0.85 DRD4 (0.55) DRD4DRD3DRD2CYP3A4CYP1A2
SCHEMBL9867489 0.84 DRD4 (0.49) DRD4DRD3DRD2CYP3A4CYP1A2
SCHEMBL9866959 0.83 DRD4 (0.56) DRD4DRD3DRD2ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026858-A Used for treating nausea, vomating, gastrointestinal disorders and centarl nervous system WALTON S.A. (ES) 1991-06-25 US disclosed